Effects of polysaccharopeptide from Trametes Versicolor and amoxicillin on the gut microbiome of healthy volunteers: A randomized clinical trial
Open accessThe DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Interactions between the microbial flora of the intestine and the human host play a critical role inmaintaining intestinal health and in the pathophysiology of a wide variety of disorders such as antibiotic associated diarrhea, Clostridium difficile infection, and inflammatory bowel disease. Prebiotics can confer health benefits by beneficial effects on the intestinal microbiome, whereas antibiotics can disrupt the microbiome leading to diarrhea andother side effects. AIM: To compare the effects of the prebiotic, polysaccharopeptide from Trametes versicolor, to those of the antibiotic,amoxicillin, on the human gut microbiome METHODS: Twenty-four healthy volunteers were randomized to receive PSP, amoxicillin, or no treatment (control).Stool specimens were analyzed using bTEFAP microbial ecology methods on seven occasions over 8 weeks from each participant in the active treatment groups and on three occasions for the controls. RESULTS: Twenty-two of 24 participants completed the protocol. PSP led to clear and consistent microbiome changes consistent with its activity as a prebiotic. Despite the diversity of the human microbiome we noted strong microbiome clustering among subjects. Baseline microbiomes tended to remain stable and to overshadow the treatment effects.Amoxicillin treatment caused substantial microbiome changes most notably an increase in Escherichia/Shigella. Antibiotic associated changes persisted to the end of the study, 42 days after antibiotic therapy ended. CONCLUSIONS: The microbiomes of healthy individuals show substantial diversity but remain stable over time.The antibiotic amoxicillin alters the microbiome and recovery from this disruption can take several weeks. PSP from T. versicolor acts as a prebiotic to modulate human intestinal microbiome composition.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Dethlefsen, L., Huse, S., Sogin, M. L., & Relman, D. A. (2008) · PLoS Biology · doi:10.1371/journal.pbio.0060280 · Cited by 2,361 · cited 1×
“Conversely, antimicrobial drugs disrupt the normal gut microbiome, usually as an inadvertent side effect, during their therapeutic use for systemic infections.(13-15) This disruption frequently results in candida overgrowth, simple AAD, and, occasionally, in the more serious condition of CDI.”
BackgroundDowd, S. E., Callaway, T. R., Wolcott, R. D., Sun, Y., McKeehan, T., Hagevoort, R. G., & Edrington, T. S. (2008) · BMC Microbiology · doi:10.1186/1471-2180-8-125 · Cited by 1,121 · cited 4×
“Microbiome analyses DNA was extracted from swabs as described previously.(43-47) Amplicon pyrosequencing (bTEFAP®) was originally described by Dowd et al.”
BackgroundMethodInfluentialGarrett, W. S., Gallini, C. A., Yatsunenko, T., Michaud, M., DuBois, A., Delaney, M. L., Punit, S., Karlsson, M., Bry, L., Glickman, J. N., et al. (2010) · Cell Host & Microbe · doi:10.1016/j.chom.2010.08.004 · Cited by 788 · cited 1×
“Increases in the relative abundance of intestinal Enterobacteriaceae, particularly Escherichia coli have also been reported in human IBD and in murine colitis caused by chemicals, pathogens or immune alterations.(26-33) Hence Table 1.”
BackgroundSILK, D. B. A., DAVIS, A., VULEVIC, J., TZORTZIS, G., & GIBSON, G. R. (2009) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2008.03911.x · Cited by 551
THE MICROBIAL CONTRIBUTION TO HUMAN FAECAL MASS
Stephen, A. M., & Cummings, J. H. (1980) · Journal of Medical Microbiology · doi:10.1099/00222615-13-1-45 · Cited by 545 · cited 3×
“There are trillions of microbes in the normal human gut of which bacteria are most abundant forming almost 60% of fecal mass and numbering >10(12) per gram of stool.(1-3) Recent research has established many vital functions for gut microbes including: metabolic activities that lead to the salvage of energy and absorba…”
BackgroundLupp, C., Robertson, M. L., Wickham, M. E., Sekirov, I., Champion, O. L., Gaynor, E. C., & Finlay, B. B. (2007) · Cell Host & Microbe · doi:10.1016/j.chom.2007.08.002 · Cited by 501
Heimesaat, M. M., Fischer, A., Siegmund, B., Kupz, A., Niebergall, J., Fuchs, D., Jahn, H.-K., Freudenberg, M., Loddenkemper, C., Batra, A., et al. (2007) · PLoS ONE · doi:10.1371/journal.pone.0000662 · Cited by 213
Research works printed but not linked: 40
- 10.1053/j.gastro.2008.10.080 · DOI · Paper page
- 10.1016/S0140-6736(03)12489-0 · DOI · Paper page
- 10.1024/0300-9831/a000112 · DOI · Paper page
- 10.2174/187221308784543656 · DOI
- 10.1111/j.1753-4887.2007.tb00272.x · DOI · Paper page
- 10.1016/S0306-3623(97)00076-1 · DOI · Paper page
- Wasser SP, 1999, Crit Rev Immunol, 19, 65
- Kidd PM, 2000, Altern Med Rev, 5, 4
- Fisher M, 2002, Anticancer Res, 22, 1737
- 10.1007/s11130-013-0342-4 · DOI
- 10.1099/mic.0.040618-0 · DOI · Paper page
- 10.1007/s00248-007-9356-5 · DOI
- 10.1128/JCM.42.3.1203-1206.2004 · DOI · Paper page
- 10.1016/S1473-3099(01)00066-4 · DOI · Paper page
- 10.1016/S0399-8320(10)70025-7 · DOI
- 10.1111/j.1365-2036.2004.02062.x · DOI · Paper page
- 10.1038/nature09944 · DOI · Paper page
- 10.1128/mBio.00260-11 · DOI · Paper page
- 10.1038/ismej.2007.29 · DOI
- 10.4161/gmic.21288 · DOI · Paper page
- 10.1128/AEM.00990-06 · DOI
- 10.1079/AHR2005105 · DOI · Paper page
- 10.1073/pnas.0706625104 · DOI · Paper page
- 10.1136/gut.52.2.237 · DOI · Paper page
- 10.1053/j.gastro.2004.03.054 · DOI · Paper page
- 10.1128/IAI.01432-07 · DOI · Paper page
- 10.1111/j.1462-2920.2009.01883.x · DOI · Paper page
- 10.1016/j.jhep.2013.11.034 · DOI · Paper page
- 10.4161/gmic.22728 · doi:10.4161/gmic.22728
- 10.1111/1751-7915.12049 · DOI
- 10.1016/j.anaerobe.2012.08.005 · DOI
- 10.1021/jf303741h · DOI
- 10.3945/ajcn.112.038893 · DOI · Paper page
- 10.1111/j.1753-4887.2009.00230.x · DOI · Paper page
- 10.1111/1750-3841.12160 · DOI
- 10.1093/bioinformatics/btq461 · DOI · Paper page
- 10.1371/journal.pone.0026732 · DOI · Paper page
- 10.1089/fpd.2008.0107 · DOI · Paper page
- 10.1038/ismej.2010.162 · DOI · Paper page
- 10.1128/AEM.03006-05 · DOI · Paper page
Cited by
So, D., Whelan, K., Rossi, M., Morrison, M., Holtmann, G., Kelly, J. T., Shanahan, E. R., Staudacher, H. M., & Campbell, K. L. (2018) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/nqy041 · Cited by 683
Effects of antibiotics on gut microbiota
Lange, K., Buerger, M., Stallmach, A., & Bruns, T. (2016) · Digestive Diseases · doi:10.1159/000443360 · Cited by 607
Faecalibacterium: a bacterial genus with promising human health applications
Martín, R., Rios-Covian, D., Huillet, E., Auger, S., Khazaal, S., Bermúdez-Humarán, L. G., Sokol, H., Chatel, J.-M., & Langella, P. (2023) · FEMS Microbiology Reviews · doi:10.1093/femsre/fuad039 · Cited by 566
The effect of antibiotics on the composition of the intestinal microbiota—a systematic review
Zimmermann, P., & Curtis, N. (2019) · Journal of Infection · doi:10.1016/j.jinf.2019.10.008 · Cited by 383
The initial state of the human gut microbiome determines its reshaping by antibiotics
Raymond, F., Ouameur, A. A., Déraspe, M., Iqbal, N., Gingras, H., Dridi, B., Leprohon, P., Plante, P.-L., Giroux, R., Bérubé, È., et al. (2016) · The ISME Journal · doi:10.1038/ismej.2015.148 · Cited by 358
A Critical Review on Health Promoting Benefits of Edible Mushrooms through Gut Microbiota
Jayachandran, M., Xiao, J., & Xu, B. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18091934 · Cited by 294
Oliver, A., Chase, A. B., Weihe, C., Orchanian, S. B., Riedel, S. F., Hendrickson, C. L., Lay, M., Sewall, J. M., Martiny, J. B. H., & Whiteson, K. (2021) · mSystems · doi:10.1128/msystems.00115-21 · Cited by 171
Metadata
- Authors
- Pallav, K., Dowd, S. E., Villafuerte, J., Yang, X., Kabbani, T., Hansen, J., Dennis, M., Leffler, D. A., Newburg, D. S., & Kelly, C. P.
- Venue
- Gut Microbes
- Publisher
- Informa UK Limited
- Published
- 2014-07
- Volume
- 5
- Issue
- 4
- Pages
- 458-467
- ISSN
- 1949-0976 (ISSN-L)
- 1949-0984
- OpenAlex
- W1549558805
- Cited by
- 87
- References
- 7
- FWCI
- 1.58
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.